Common questions about Tham (FAQ)
Q: Is Tham the same as sodium bicarbonate?
No. Official documents describe Tham as a non-bicarbonate buffer base, meaning it works differently than the body's natural bicarbonate system. While both agents are used to adjust the body's acid-base balance, Tham's chemical action involves directly binding to acid in the blood and is mainly eliminated by the kidneys. Sodium bicarbonate primarily works by being converted into carbon dioxide, which is then removed by the lungs.
Q: How quickly does Tham start to work after being given?
Tham is administered via slow intravenous infusion, meaning it is introduced into the bloodstream gradually over time. According to the mechanism of action, the chemical buffering action is described to begin as the drug is introduced, binding immediately to acid in the blood.
Q: How long do the effects of Tham typically last?
Regulatory labeling indicates that Tham is intended for short-term use, and official guidance generally advises against administration for more than one day, except in life-threatening situations. Due to its powerful effects on body chemistry, continuous oversight and frequent monitoring of blood values are specified throughout and following therapy.
Q: Can Tham be given to children?
Yes, official labeling provides specific guidelines for pediatric use. Dosage information is detailed for infants and neonates with acidosis linked to Respiratory Distress Syndrome. However, it is strictly stated that Tham is contraindicated (not allowed) in neonates who have chronic respiratory acidosis.
Q: Is it necessary to check blood tests when a person is receiving Tham?
Regulatory documents specify that frequent monitoring is needed. Blood tests for pH (acidity level), blood sugar (glucose), and electrolytes like potassium must be performed before, during, and after administration. This is a safety requirement due to the risk of significant changes in blood chemistry, including low blood sugar.
Q: Is Tham available as a pill or only as an injection?
Official regulatory documents confirm that Tham is only supplied and approved as a sterile solution for injection. It is specifically formulated as a liquid for immediate administration into a vein, and no oral (pill) dosage form is described in the product information.
Q: Is Tham a common medication used in emergency situations?
Official information indicates that Tham is reserved for critical, high-acuity contexts. It is indicated for use in life-threatening situations, such as severe metabolic acidosis related to cardiac bypass surgery and during cardiac arrest, indicating its use in critical and acute clinical settings.
Q: Are there any religious or dietary considerations for Tham?
Official drug interaction documentation states that the product label does not document any known interactions with food, alcohol, or herbal products. Furthermore, no specific religious or general dietary constraints are noted in the regulatory warnings or precautions sections.
Q: How is Tham typically stored in a hospital setting?
Official guidelines require Tham to be stored at Controlled Room Temperature, between 20 C and 25 C (68 F and 77 F). The product must be protected from freezing, and for patient safety, it should be stored out of the sight and reach of children.
Q: What is the purpose of Tham in cardiac surgery?
Tham is used during cardiac bypass surgery primarily to manage or prevent metabolic acidosis, which can be a complication during the procedure. It is also used to correct the acidity of the ACD blood that may be used to prime or prepare the cardiac bypass equipment.
Q: Does Tham affect the way certain antibiotics work?
As a systemic alkalizing agent, Tham can potentially raise the pH of the urine. Official documents note that this change can alter the excretion rate of other medications that are weak acids or bases, which could include certain antibiotics, though no specific antibiotic classes are singled out.
Q: Why is Tham sometimes used in pediatric critical care?
The use of Tham in pediatric critical care is generally restricted to specific, acute conditions. Official dosing instructions are provided for neonates and infants who have acidosis linked to Respiratory Distress Syndrome.
Q: Is there a link between Tham and low potassium levels?
The official adverse reaction list for Tham does not directly list low potassium levels (hypokalemia) as a reported side effect. However, the label does note the risk of hyperkalemia (high potassium) as a concern, especially in patients with kidney problems.
Q: Is there a risk of fluid retention with Tham?
Yes, official regulatory warnings state that the intravenous administration of Tham can lead to fluid and solute overloading. This risk may cause overhydration, a congested state, or the development of pulmonary edema (fluid in the lungs).
Q: Can Tham be administered outside of a hospital setting?
The administration instructions for Tham emphasize the need for a slow intravenous infusion through a large vein or catheter, along with continuous monitoring of blood tests. These requirements indicate that the drug is intended for use in controlled clinical settings, such as a hospital or critical care unit.
Q: How does the body eliminate or break down Tham?
The tromethamine molecule is primarily eliminated from the body unchanged via the kidneys (renal excretion). Because of this elimination route, regulatory documents emphasize the need for caution and care when administering the drug to patients with known kidney disease or reduced urinary output.
Q: What information is available about Tham use during pregnancy?
Official regulatory warnings state that use during pregnancy should occur only if clearly needed. The label also notes that animal reproduction studies and controlled clinical data in human pregnancy have not been conducted.
Q: What precautions are noted for patients with liver problems using Tham?
While the primary contraindications relate to kidney function, the regulatory labeling notes that dose selection for older adults requires caution due to the greater frequency of decreased function in organs like the kidneys, heart, or liver. This suggests that liver (hepatic) function is a factor considered in treatment safety.
Q: Has Tham ever been recalled by regulatory bodies?
The FDA database does contain records of past recalls. These instances typically involved specific kits that contained Tham solution, and the recalls were often related to issues like precipitation (particle formation) observed in some bottles.
Q: Does Tham require reconstitution before use?
No. Official documents describe Tham as being supplied as a sterile solution for injection. This means it is already in a liquid, ready-to-use form and does not require mixing or reconstitution before it is administered intravenously.
Q: What is the process for disposing of unused Tham product?
Official instructions specify that any unused portion remaining in the container after treatment should be discarded. Disposal of the drug, the container, and related waste must follow local procedures and guidelines for pharmaceutical waste.
Q: Are there any known interactions between Tham and blood pressure medications?
Official documents describe that Tham can cause shifts in the body's pH and electrolyte balance. Because of these systemic changes, the effects of co-administered drugs, which may include some cardiovascular (blood pressure) medications, could be altered, though no specific class of blood pressure drugs is formally contraindicated.
